GlassScriptPhysician profile
Christopher M Mallow
NPI 1326333279
$845.62
in general payments reported to CMS, 2019-2025
12 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $337 · 2024: $79.86 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $235.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $219.68 | 2019-2020 | |
| Glaxosmithkline, LLC. | $180.93 | 2019-2020 | |
| Medline Industries LP | $91.46 | 2025 | |
| Masimo Corporation | $79.86 | 2024 | Set and Rainbow Set |
| Mylan Specialty L.P. | $66.06 | 2019-2020 | |
| Medtronic, INC. | $64.42 | 2025 | Vitalflow Console, Simulus |
| Regeneron Healthcare Solutions, INC. | $31.59 | 2020 | |
| Merck Sharp & Dohme LLC | $30.13 | 2020 | |
| La Jolla Pharmaceutical Company | $25.23 | 2020 | |
| Mallinckrodt Enterprises LLC | $22.83 | 2019 | |
| United Therapeutics Corporation | $18.96 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Mallow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.